Mercado de tomografia computorizada cardíaca (CCT) da América do Norte – Tendências do setor e previsão para 2028

Análise de mercado e insights: Mercado de tomografia computorizada cardíaca (CCT) da América do Norte

Espera-se que o mercado de tomografia computorizada cardíaca (CCT) ganhe um crescimento significativo no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado de tomografia computorizada cardíaca (CCT) da América do Norte está a crescer com um CAGR de 6,5% na previsão período de 2021 a 2028 e deverá atingir os 1.143,87 milhões de dólares até 2028, contra os 705,52 milhões de dólares em 2020. O aumento dos gastos em saúde e a escalada na inovação e nas tecnologias são os principais impulsionadores esperados para o crescimento do mercado no período de previsão.

A tomografia computorizada cardíaca (TC) é um processo de imagem que utiliza raios X para mostrar detalhes das artérias e veias do coração. As imagens são utilizadas para determinar se as placas ou depósitos de cálcio estão presentes nos vasos sanguíneos e se estão a causar bloqueio. A TC cardíaca utiliza tecnologia avançada de TC com contraste (corante) intravenoso (IV) para visualizar a anatomia cardíaca, a circulação coronária e os grandes vasos. Uma tomografia computorizada cardíaca também pode ser chamada de angiografia coronária por TC, MSCT, TC, TC cardíaca, CTA coronária ou tomografia computorizada cardíaca.

A crescente prevalência de doenças cardiovasculares e o aumento dos gastos em saúde aceleraram a necessidade de tomografia computorizada cardíaca para o diagnóstico de doenças nas unidades de saúde. O aumento das inovações e tecnologias, juntamente com o aumento do financiamento governamental, está também a impulsionar o crescimento do mercado.

A crescente procura de diagnóstico e testes devido ao aumento do número de doentes cardíacos em todo o mundo e o aumento das atividades de I&D estão a impulsionar a procura pelo mercado global de tomografia computorizada cardíaca (CCT) no período de previsão. No entanto, as políticas regulamentares rigorosas podem dificultar o crescimento do mercado de tomografia computorizada cardíaca (CCT) no período de previsão.

The cardiac computed tomography (CCT) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Cardiac Computed Tomography (CCT) Market Scope and Market Size

The cardiac computed tomography (CCT) market is segmented on the basis of offerings, product type, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of offerings, the cardiac computed tomography (CCT) market is segmented into system, service and software. In 2021, system segment is expected to dominate the market due to increasing prevalence of this various disease type among target population.
• On the basis of product type, the cardiac computed tomography (CCT) market is segmented into single source CT, dual source cardiac CT and spectral CT. In 2021, single source CT segment is expected to dominate the market because of technological advancement and increasing healthcare expenditure.
• On the basis of application, the cardiac computed tomography (CCT) market is segmented into calcium scoring, coronary CT angiography, device implantation, pulmonary vein isolation and left atrial appendage occlusion. In 2021, calcium scoring segment expected to dominate the market due to rising cardiovascular disease among the target population
• On the basis of end user, the cardiac computed tomography (CCT) market is segmented into hospitals, speciality centers, diagnostic & imaging centers and others. In 2021, hospitals segment is expected to dominate the market because of surging pool of cardiac  patients.
• On the basis of distribution channel, the cardiac computed tomography (CCT) market is segmented into direct tender and third party distributor. In 2021, direct tender segment is expected to dominate the market due to the presence of large number of market players and increasing R & D activities.

Cardiac Computed Tomography (CCT) Market Country Level Analysis

The cardiac computed tomography (CCT) market is analyzed and market size information is provided based offerings, product type, application, end user, and distribution channel.

The countries covered in the cardiac computed tomography (CCT) market report are U.S., Canada, and Mexico.

North America is expected to dominate the cardiac computed tomography (CCT) market due to rising technological advancement in the region. The U.S. is dominating in the market and leading the growth in the global cardiac computed tomography (CCT) market due to rising prevalence of cardiac disease.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Rising healthcare expenditure and escalation in innovations and technologies in the cardiac computed tomography (CCT) market are creating new opportunities for players in the global cardiac computed tomography (CCT) market

The cardiac computed tomography (CCT) market also provides you with detailed market analysis for every country growth in industry with drugs sales, impact of advancement, technology and changes in regulatory scenarios with their support for the cardiac computed tomography (CCT). The data is available for historic period 2010 to 2019.      

Competitive Landscape and Cardiac Computed Tomography (CCT) Market Share Analysis

The cardiac computed tomography (CCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to cardiac computed tomography (CCT) market.

The major companies which are dealing in the cardiac computed tomography (CCT) market are Siemens Healthcare GmbH, Neusoft Corporation, Shenzhen Anke High-tech Co., Ltd., Arineta, Medviso.com, SinoVision, United Imaging Healthcare Co., Ltd. , Koninklijke Philips N.V., GE Healthcare (A subsidiary of General Electric), CANON MEDICAL SYSTEMS CORPORATION (A Subsidiary of Canon Inc.), FUJIFILM Corporation  among others domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies worldwide, which are further accelerating the cardiac computed tomography (CCT) market.

For instance,

• Em março de 2018, a Hikma Pharmaceuticals PLC anunciou uma parceria global de 4 anos com a Direct Relief, uma das principais organizações de cuidados de saúde do mundo, como parte do lançamento da sua nova marca corporativa anunciada com o objetivo de colocar uma melhor saúde ao alcance das pessoas em todo o mundo. O compromisso de financiamento para os próximos anos, bem como o fornecimento de medicamentos de qualidade permitirão. Isto ajudará a empresa a expandir o seu negócio e a fortalecer o perfil do produto.
• Em agosto de 2021, a Differin, uma parceria para melhorar o acesso à água potável em La Guajira, na Colômbia, uma das regiões com maior dificuldade hídrica do país. Uma doação de 1,5 milhões de dólares da Fundação está a alimentar a iniciativa de três anos que visa garantir que milhares de crianças, adolescentes, famílias e comunidades beneficiem de serviços básicos de água, saneamento e higiene (WASH) através de uma estratégia multifacetada que se centra na reabilitação, educação e colaboração.. Isto impulsionou o crescimento do mercado e auxilia na geração de receitas.

SKU-66121